Citation Impact
Citing Papers
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Langerhans Cell (Eosinophilic) Granulomatosis
1996 StandoutNobel
Review: Immunoglobulin Light Chain Amyloidosis—The Archetype of Structural and Pathogenic Variability
2000
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
2008
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
2015
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial
2000
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Ocular Graft-versus-Host Disease: A Review
2013
Neutrophils at work
2014 Standout
A comparison of related donor peripheral blood and bone marrow transplants: Importance of late-onset chronic graft-versus-host disease and infections
2003
Molecular classification of T-cell lymphomas
2009
Advances in stem cell mobilization
2012
Classification of Cutaneous Lymphoma
1999
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Wnt signaling in cancer
2016 Standout
Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006
2010
Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow
2004
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Primary cutaneous γ/δ T-Cell Lymphoma Presenting as Disseminated Pagetoid Reticulosis
1991
Mesenchymal stem cells in health and disease
2008 Standout
Network medicine: a network-based approach to human disease
2010 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Epigenetic control of gene expression: Potential implications for cancer treatment
2017
TFOS DEWS II pathophysiology report
2017 Standout
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
2013
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs
2005
Chronic graft-versus-host disease
2003 Standout
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
2004
Antibody therapy of cancer
2012 Standout
Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas
1998
β-Edge Interactions in a Pentadecameric Human Antibody Vκ Domain
2006 StandoutNobel
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Cardiovascular toxicity of molecularly targeted agents
2009
Sciatic nerve compression following bone marrow harvest
2000
Graft-versus-host disease
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Hepatosplenic ɑß T-Cell Lymphomas
2001
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
2003
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
2000
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Systemic amyloidosis
2015 Standout
Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV
2010
Hematopoietic Stem-Cell Transplantation
2006 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Allogeneic transplantation of blood stem cells: Coming of age?
2001
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
2007
Classification of cytotoxic T-cell and natural killer cell lymphomas
2003
Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohnʼs disease: A cautionary tale?
2007
CD4− CD8− `Double-Negative' Cutaneous T-Cell Lymphomas Share Common Histologic Features and an Aggressive Clinical Course
2002
The molecular landscape of head and neck cancer
2018 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
2009
Cytotoxic T-cell and NK-cell Lymphomas
2014
Evaluation and Management of the Cardiac Amyloidosis
2007
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
T‐cell receptor γδ‐positive peripheral T‐cell lymphomas presenting in the skin:
1992
Management of Crohn's Disease in Adults
2009 Standout
Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients
2005
Molecular Mechanisms of Amyloidosis
2003 Standout
Amyloidosis and the Heart
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
1993
γδ T‐cell lymphomas: a homogeneous entity?
2000
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
2006
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients
2011
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
2002
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
1999
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
2004
S100-positive, T-cell chronic lymphoproliferative disease: an aggressive disorder of an uncommon T-cell subset
1991
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Amyloidosis: Pathogenesis and New Therapeutic Options
2011
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
2004
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
Combination therapy in combating cancer
2017 Standout
Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm
1997
Autologous stem cell transplantation for primary systemic amyloidosis
2002
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
2001
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.
1998
Diffuse large cell lymphoma
2011
Myeloma today: Disease definitions and treatment advances
2015
Human Adipose Tissue Is a Source of Multipotent Stem Cells
2002 Standout
Panobinostat (LBH589): A Potent Pan-Deacetylase Inhibitor with Promising Activity Against Hematologic and Solid Tumors
2009
β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL
2013
Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis
2001
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
2005
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
2000
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
2001
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Priscille Bourquelot being referenced
TAL1 expression does not occur in the majority of T‐ALL blasts
1998
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation
1998
Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients
1998
Simultaneous detection ofMYC,BVR1, andPVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization
1998
Durable Remission After Aggressive Chemotherapy for Very Late Post–Kidney Transplant Lymphoproliferation: A Report of 16 Cases Observed in a Single Center
2000
Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple Myeloma
2013
Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.
1990
A Phase IB, Multicenter, Open-Label, Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma
2008
A Phase II Study of Oral Panobinostat (LBH589) in Adult Patients with Advanced Refractory Multiple Myeloma
2008
PANORAMA1: A randomized, double-blind, placebo controlled phase III study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed multiple myeloma.
2011